Pediatric hemorrhagic cystitis

Journal of Pediatric Urology

Volumn 5, Issue 4, 2009, Pages 254-264

  Decker, Daniel B ^a   Karam, Jose A ^a   Wilcox, Duncan T ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

BK virus; Bone marrow transplant; Cidofovir; Hemorrhagic cystitis; Hyperbaric oxygen; Pediatric

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AMINOCAPROIC ACID; ANALGESIC AGENT; BLOOD CLOTTING FACTOR 7; BUSULFAN; CARBOPROST TROMETAMOL; CEPHALOSPORIN DERIVATIVE; CIDOFOVIR; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ESTROGEN; FIBRIN GLUE; FLUCONAZOLE; HYALURONIC ACID; MESNA; PENICILLIN DERIVATIVE; PENTOSAN POLYSULFATE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; RISPERIDONE; SPASMOLYTIC AGENT;

ABSENCE OF SIDE EFFECTS; ACIDOSIS; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTIFICIAL EMBOLISM; BK VIRUS; BLADDER INJURY; BLADDER IRRIGATION; BLADDER SPASM; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; CAUTERIZATION; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYSTECTOMY; CYSTOSCOPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG TISSUE LEVEL; ECHOGRAPHY; FEMINIZATION; FLUSHING; HEMORRHAGIC CYSTITIS; HUMAN; HYPERBARIC OXYGEN; HYPERCOAGULABILITY; HYPERTENSION; INCIDENCE; INFORMATION RETRIEVAL; INTERSTITIAL CYSTITIS; LIVER DYSFUNCTION; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; MALIGNANT TRANSFORMATION; MEDLINE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEPHROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SEIZURE; SEPSIS; SIDE EFFECT; URINARY DIVERSION; VIRUS IDENTIFICATION; VIRUS INFECTION;

BK VIRUS; BONE MARROW TRANSPLANTATION; CHILD; CYSTITIS; HEMORRHAGE; HUMANS; HYPERBARIC OXYGENATION; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 70149089225     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2009.02.199     Document Type: Review

References (96)

1. Hale G.A., Rochester R.J., Heslop H.E., Krance R.A., Gingrich J.R., Benaim E., et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant 9 (2003) 698-705
2. Gorczynska E., Turkiewicz D., Rybka K., Toporski J., Kalwak K., Dyla A., et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 11 (2005) 797-804
3. Hassan Z., Remberger M., Svenberg P., Elbander M., Omazic B., Mattsson J., et al. Hemorrhagic cystitis: a retrospective single-center survey. Clin Transplant 21 (2007) 659-667
4. Vögeli T.A., Peinemann F., Burdach S., and Ackermann R. Urologic treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol 36 (1999) 252-257
5. Vose J.M., Reed E.C., Pippert G.C., Anderson J.R., Bierman P.J., Kessinger A., et al. Mesna compared with CBI as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol 11 7 (1993) 1306-1310
6. Droller M.J., Saral R., and Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. J Urol 20 3 (1982) 256-258
7. Pode D., Perlberg S., and Steiner D. Busulfan-induced hemorrhagic cystitis. J Urol 130 (1983) 347
8. Russell S.J., Vowels M.R., and Vale T. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 13 5 (1994) 533-539
9. Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23 3 (1999) 277-282
10. Leung A.Y., Suen C.K., Lie A.K., Liang R.H., Yuen K.Y., and Kwong Y.L. Quantification of polyoma BK viruria in HC complicating BMT. Blood 98 (2001) 1971-1978
11. Chakrabarti S., Osman H., Collingham K., and Milligan D.W. Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning. Bone Marrow Transplant 31 (2003) 379-386
12. Iwamoto S., Azuma E., Hori H., Hirayama M., Kobayashi M., Komada Y., et al. BKV-associated fatal renal failure following late-onset hemorrhagic cystitis in unrelated bone marrow transplantation. Pediatr Hematol Oncol 19 (2002) 255-261
13. Ambinder R.F., Burns W., Forman M., Charache P., Arthur R., Beschorner W., et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 146 (1986) 1400-1401
14. Gardner S.D., Field A.M., Coleman D.V., and Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1 (1971) 1253-1257
15. Shah K.V. Polyomaviruses. Fields virology. 3rd ed. (1996), Lippincott-Raven, Philadelphia
16. Reploeg M.D., Storch G.A., and Clifford D.B. BK virus: a clinical review. Clin Infect Dis 33 (2001) 191-202
17. Elidemir O., Chang I.F., Schecter M.G., and Mallory G.B. BK virus-associated hemorrhagic cystitis in a pediatric lung transplant recipient. Pediatr Transplant 11 (2007) 807-810
18. Hirsch H.H., Brennan D.C., Drachenberg C.B., Ginevri F., Gordon J., Limaye A.P., et al. Polyomavirus associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79 (2005) 1277-1286
19. Pahari A., and Rees L. BK virus-associated renal problems-clinical implications. Pediatr Nephrol 18 (2003) 743-748
20. Arthur R.R., Shah K.V., Baust S.J., Santos G.W., and Saral R. Association of BK viruria with hemorrhagic cystitis is recipients of bone marrow transplants. N Engl J Med 24 315 (1986) 230-234
21. Bedi A., Miller C.B., Hanson J.L., Goodman S., Ambinder R.F., Charache P., et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 13 (1995) 1103-1109
22. Cesaro S., Facchin C., Tridello G., Messina C., Calore E., Biasolo M.A., et al. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 41 (2008) 363-370
23. Erard V., Kim H.W., Corey L., Limaye A., Huang M.L., Myerson D., et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 106 (2005) 1130-1132
24. Giraud G., Bogdanovic G., Priftakis P., Remberger M., Svahn B.M., Barkholt L., et al. The incidence of hemorrhagic cystitis and BK viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Hematol J 91 (2006) 401-404
25. Azzi A., Cesaro S., Laszlo D., Zakrzewska K., Ciappi S., De Santis R., et al. Human polyomavirus BK load and HC in BMT patients. J Clin Virol 14 (1999) 79-86
26. Bogdanovic G., Priftakis P., Taemmeraes B., Gustafsson A., Flaegstad T., Winiarski J., et al. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children. Pediatr Transplant 2 (1998) 288-293
27. Cox P.J. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Pharmacol 28 (1979) 2045-2049
28. Moriyama Y., Koike T., and Shibata A. Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis. Jpn J Clin Oncol 14 (1984) 531-536
29. Phillips F.S., Sternberg S.S., Cronin A.P., and Vidal P.M. Cyclophosphamide and urinary bladder toxicity. Cancer Res 21 (1961) 1577-1589
30. Seber A., Shu X.O., Defor T., Sencer S., and Ramsay N. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 23 (1999) 35-40
31. Andriole G.L., Sandlund J.T., Miser J.S., Arasi V., Linehan M., and Magrath I.T. The efficacy of mesna as an uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. J Clin Oncol 5 (1987) 799-803
32. Hows J.M., Mehta A., Ward L., Woods K., Perez R., Gordon M.Y., et al. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomized study. Br J Cancer 50 (1984) 753-756
33. Shepherd J.D., Pringle L.E., Barnett M.J., Klingemann H.G., Reece D.E., and Phillips G.L. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 9 (1991) 2016-2020
34. Turkeri L.N., Lum L.G., Uberti J.P., Abella E., Momin F., Karanes C., et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. J Urol 153 (1995) 637-640
35. Hadjibabaie M., Alimoghaddam K., Shamshiri A.R., Iravani M., Bahar B., Mousavi A., et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol 26 (2008) 43-46
36. deVries C.R., and Freiha F.S. Hemorrhagic cystitis: a review. J Urol 143 (1990) 1-9
37. Donahue L.A., and Frank I.N. Intravesical formalin for hemorrhagic cystitis: analysis of therapy. J Urol 141 (1989) 809-812
38. Godec C., and Gleich P. Intractable hematuria and formalin. J Urol 130 (1983) 688-691
39. Jerkins G.R., Noe H.N., and Hill D.E. An unusual complication of silver nitrate treatment of hemorrhagic cystitis: case report. J Urol 136 (1986) 456-458
40. Efros M.D., Ahmed T., Coombe N., and Choudhury M.S. Urologic complications of high-dose chemotherapy and bone marrow transplantation. Urology 43 (1994) 355-360
41. Goel A.K., Rao M.S., Bhagwat A.G., Vaidyanathan S., Goswami A.K., and Sen T.K. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol 133 (1985) 956-957
42. Gattegno B., Guillemenot F., Fiatte P., Cohen L., Becker A., Gluckman E., et al. Treatment of HC caused by cyclophosphamide using intravesical instillation of potassium alum. A propos of 5 cases. Ann Urol 24 (1990) 190-192
43. Murphy C.P., Cox R.L., Harden E.A., Stevens D.A., Heye M.M., and Herzig R.H. Encephalopathy and seizures induced by intravesical alum irrigations. Bone Marrow Transplant 10 (1992) 383-385
44. Perazella M., and Brown E. Acute aluminum toxicity and alum bladder irrigation in patients with renal failure. Am J Kidney Dis 21 (1993) 44-46
45. Kanwar V.S., Jenkins J.J., Mandrell B.N., and Furman W.L. Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis. Med Pediatr Oncol 27 (1996) 64-67
46. Ippoliti C., Przepiorka D., Mehra R., Neumann J., Wood J., Claxton D., et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology 46 (1995) 811-815
47. Levine L., and Jarrard D. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol 149 (1993) 719-723
48. Trigg M.E., O'Reilly J., Rumelhart S., Morgan D., Holida M., and de Alarcon P. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol 143 (1990) 92-94
49. Pitts T.O., Spero J.A., Bontempo F.A., and Greenberg A. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid. Am J Kidney Dis 8 (1986) 441-444
50. Lakhani A., Raptis A., Frame D., Simpson D., Berkahn L., Mellon-Reppen S., et al. Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplant 24 (1999) 1259-1260
51. Andrei G., Snoeck R., Vandeputte M., and De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrobial Agents Chemother 41 (1997) 587-593
52. De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 16 (2003) 569-596
53. Bjorang O., Tveitan H., Midtvedt K., Broch L.U., Scott H., and Andresen P.A. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant 17 (2002) 2023-2025
54. González-Fraile M.I., Cañizo C., Caballero D., Hernández R., Vázquez L., López C., et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis 3 (2001) 44-46
55. Held T.K., Biel S.S., Nitsche A., Kurth A., Chen S., Gelderblom H.R., et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 26 (2000) 347-350
56. Ribaud P., Scieux C., Freymuth F., Morinet F., and Gluckman E. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 28 (1999) 690-691
57. Savona M.R., Newton D., Frame D., Levine J.E., Mineishi S., and Kaul D.R. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 39 (2007) 783-787
58. Bridges B., Donegan S., and Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 81 (2006) 535-537
59. Fanourgiakis P., Georgala A., Vekemans M., Triffet A., De Bruyn J.M., Duchateau V., et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 40 (2005) 199-201
60. Mulholland S.G., Hanno P., Parsons C.L., Sant G.R., and Staskin D.R. Pentosan polysulfate sodium for therapy of interstitial cystitis. Urology 35 (1990) 552-558
61. Kalota S.J., Stein P.C., and Parsons C.L. Prevention of acrolein-induced bladder injury by pentosanpolysulfate. J Urol 148 (1992) 163-166
62. Parsons C.L. Successful management of radiation cystitis with sodium pentosanpolysulfate. J Urol 136 (1986) 813-814
63. Hampson S.J., and Woodhouse C.R. Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: experience with 14 patients. Eur Urol 25 (1994) 40-42
64. Toren P.J., and Norman R.W. Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulphate. J Urol 173 (2005) 103
65. Ashcroft G.S., Dodsworth J., van Boxtel E., Tarnuzzer R.W., Horan M.A., Schultz G.S., et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 3 (1997) 1209-1215
66. Deshpande R., Khalili H., Pergolizzi R.G., Michael S.D., and Chang M.D. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 38 (1997) 46-54
67. Heath J.A., Mishra S., Mitchell S., Waters K.D., and Tiedemann K. Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant 37 (2006) 523-526
68. Ordemann R., Naumann R., Geissler G., Bornhauser M., Schuler U., and Ehninger G. Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature. Bone Marrow Transplant 25 (2000) 981-985
69. Liu Y.K., Harty J.I., Steinbock G.S., Holt Jr. H.A., Goldstein D.H., and Amin M. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol 144 (1990) 41-43
70. Miller J., Burfield G.D., and Moretti K.L. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol 15 (1994) 1348-1350
71. Lupulescu A. Estrogen use and cancer risk: a review. Exp Clin Endocrinol 101 (1993) 204-214
72. Miodosky M., Abdul-Hai A., Tsirigotis P., Or R., Bitan M., Resnick I.B., et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant 38 (2006) 507-511
73. Focosi D., and Kast R.E. Hyaluronate and risperidone for hemorrhagic cystitis. Bone Marrow Transplant 39 (2007) 57
74. Ashrani A.A., Gabriel D.A., Gajewski J.L., Jacobs Jr. D.R., Weisdorf D.J., and Key N.S. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Bone Marrow Transplant 38 (2006) 825-828
75. Ringdén O., Uzunel M., Sundberg B., Lönnies L., Nava S., Gustafsson J., et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 21 (2007) 2271-2276
76. Schoenrock G.J., and Cianci P. Treatment of radiation cystitis with hyperbaric oxygen. Urology 27 (1986) 271-272
77. Bevers R.F., Bakker D.J., and Kurth K.H. Hyperbaric oxygen treatment of hemorrhagic cystitis. Lancet 346 (1995) 803-805
78. Corman J.M., McClure D., Pritchett R., Kozlowski P., and Hampson N.B. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 169 (2003) 2200-2202
79. Norkool D.M., Hampson N.B., Gibbons R.P., and Weissman R.M. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol 150 (1993) 332-334
80. Weiss J.P., Mattei D.M., Neville E.C., and Hanno P.M. Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience. J Urol 151 (1994) 1514-1517
81. Ashamalla H.L., Thom S.R., and Goldwein J.W. Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children. The University of Pennsylvania experience. Cancer 77 (1996) 2407-2412
82. Furness III P.D., Palmer L.S., Palmer J.S., Capelli-Schellpfeffer M., and Cheng E.Y. Hyperbaric oxygen therapy for pediatric hemorrhagic cystitis. J Urol 161 (1999) 1596-1597
83. Bratsas K.S., Stephanides A.A., Spyropoulos E., Zachariades B.P., and Androulakakis P.A. Hyperbaric oxygen therapy for cyclophosphamide induced refractory hemorrhagic cystitis in a child. J Urol 172 (2004) 679
84. Al-Seraihi A., and Ayas M. Hyperbaric oxygen should not be used in the management of hemorrhagic cystitis in patients with Fanconi anemia. Pediatr Blood Cancer 49 (2007) 854-856
85. Müller-Mattheis V., Jürgens H., Göbel U., and Ackermann R. Human fibrin glue as a new therapeutic concept in cyclophosphamide-induced cystitis and macrohematuria. Klin Padiatr 200 (1988) 274-278
86. Ouwenga M.K., Langston M.D., and Campbell S.C. Use of fibrin sealant in recalcitrant hemorrhagic cystitis. J Urol 172 (2004) 1348
87. Purves J.T., Graham M.L., and Ramakumar S. Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology 66 (2005) 641-643
88. Hong S.Y., Pyo S.J., and Lee H.B. Effect of serum urokinase on urine fibrinolytic activity. Nephron 55 (1990) 287-291
89. Sneiders A., and Pryor J.L. Percutaneous nephrostomy drainage in the treatment of severe hemorrhagic cystitis. J Urol 150 (1993) 966-967
90. Zagoria R.J., Hodge R.G., Dyer R.B., and Routh W.D. Percutaneous nephrostomy for treatment of intractable hemorrhagic cystitis. J Urol 149 (1993) 1449-1451
91. Gonzalez C.M., Case J.R., and Nadler R.B. Glutaraldehyde cross-linked collagen occlusion of the ureteral orifices with percutaneous nephrostomy: a minimally invasive option for treatment of refractory hemorrhagic cystitis. J Urol 166 (2001) 977-978
92. Gine E., Rovira M., Real I., Burrel M., Montana J., Carreras E., et al. Successful treatment of severe hemorrhagic cystitis after hematopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant 31 (2003) 923-925
93. Han Y., Wu D., Sun A., Xie Y., Xu J., Zhou J., et al. Selective embolization of the internal iliac arteries for the treatment of severe hemorrhagic cystitis following hematopoietic SCT. Bone Marrow Transplant 41 (2008) 881-886
94. Palandri F., Bonifazi F., Rossi C., Falcioni S., Arpinati M., Giannini M.B., et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 35 (2005) 529-530
95. Koc S., Hagglund H., Ireton R.C., Perez-Simon J.A., Collins S.J., and Appelbaum F.R. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 26 (2000) 899-901
96. Okaneya T., Kontani K., Komijama I., and Takezaki T. Severe cyclophosphamide-induced hemorrhagic cystitis successfully treated by total cystectomy with ileal neobladder substitution: a case report. J Urol 150 (1993) 1909-1910